CervoMed Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
CervoMed Inc. (CRVO) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 10.79 million shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-07
- CervoMed Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 10.79M shares, a 199.89% increase year-over-year.
- CervoMed Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 3.60M shares, a 478.56% increase year-over-year.
- CervoMed Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 621.72K shares, a 82.18% decline year-over-year.
- CervoMed Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-09-30 was 927.80K shares, a 73.62% decline year-over-year.
- CervoMed Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 3.59M shares, a 10.63% increase from fiscal 2024.
- CervoMed Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 3.25M shares, a 618.41% increase from fiscal 2023.
- CervoMed Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 451.85K shares, a 87.05% decline from fiscal 2022.
- CervoMed Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 3.49M shares, a 1577.95% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 10.79M shares 10-Q · filed 2026-08-07 | 3.86M shares 10-Q · filed 2026-05-15 | ||||||
| 2025-12-31 | 3.59M shares 10-K · filed 2026-03-13 | |||||||
| 2025-09-30 | 3.60M shares 10-Q · filed 2025-11-07 | |||||||
| 2025-06-30 | 3.60M shares 10-Q · filed 2025-08-08 | |||||||
| 2025-03-31 | 3.60M shares 10-Q · filed 2026-08-07 | 3.52M shares 10-Q · filed 2025-05-12 | ||||||
| 2024-12-31 | 3.25M shares 10-K · filed 2026-03-13 | |||||||
| 2024-09-30 | 3.17M shares 10-Q · filed 2025-11-07 | |||||||
| 2024-06-30 | 3.17M shares 10-Q · filed 2025-08-08 | |||||||
| 2024-03-31 | 621.72K shares 10-Q · filed 2025-05-12 | |||||||
| 2023-12-31 | 451.85K shares 10-K · filed 2025-03-17 | 947.84K shares 10-K · filed 2024-03-29 | ||||||
| 2023-09-30 | 927.80K shares 10-Q · filed 2023-11-13 | 927.80K shares 10-Q · filed 2024-11-12 | ||||||
| 2023-06-30 | 3.49M shares 10-Q · filed 2024-08-09 | 176.71K shares 10-Q · filed 2023-08-08 | ||||||
| 2023-03-31 | 3.49M shares 10-Q · filed 2024-05-14 | 195.21K shares 10-Q · filed 2023-05-15 | ||||||
| 2022-12-31 | 3.49M shares 10-K · filed 2024-03-29 | 255.58K shares 10-K · filed 2023-03-24 | ||||||
| 2022-09-30 | 3.52M shares 10-Q · filed 2023-11-13 | 257.55K shares 10-Q · filed 2022-11-14 | ||||||
| 2022-06-30 | 239.44K shares 10-Q · filed 2023-08-08 | |||||||
| 2022-03-31 | 233.64K shares 10-Q · filed 2023-05-15 | |||||||
| 2021-12-31 | 207.95K shares 10-K · filed 2023-03-24 | 10.40M shares 10-K · filed 2022-03-18 | ||||||
| 2021-09-30 | 211.81K shares 10-Q · filed 2022-11-14 | 10.59M shares 10-Q · filed 2021-11-10 | ||||||
| 2021-06-30 | 194.11K shares 10-Q · filed 2022-08-12 | 9.71M shares 10-Q · filed 2021-08-11 | ||||||
| 2021-03-31 | 178.36K shares 10-Q · filed 2022-05-12 | 9.82M shares 10-Q · filed 2021-05-07 | ||||||
| 2020-12-31 | 11.49M shares 10-K · filed 2022-03-18 | 11.34M shares 10-K · filed 2021-03-17 | ||||||
| 2020-09-30 | 11.29M shares 10-Q · filed 2021-11-10 | |||||||
| 2020-06-30 | 10.64M shares 10-Q · filed 2021-08-11 | |||||||
| 2020-03-31 | 22.54M shares 10-Q · filed 2020-05-11 | |||||||
| 2020-03-30 | 22.54M shares 10-Q · filed 2021-05-07 | |||||||
| 2019-12-31 | 22.69M shares 10-K · filed 2021-03-17 | |||||||
| 2019-09-30 | 3.78M shares 10-Q · filed 2020-11-12 | |||||||
| 2019-06-30 | 3.78M shares 10-Q · filed 2020-08-07 | |||||||
| 2019-03-31 | 2.34M shares 10-Q · filed 2020-05-11 | |||||||
| 2018-12-31 | 2.29M shares 10-K · filed 2020-03-17 | |||||||
| 2018-09-30 | 34.52M shares 10-Q · filed 2018-11-13 | 2.30M shares 10-Q · filed 2019-11-08 | 34.52M shares 10-Q · filed 2018-11-13 | |||||
| 2018-06-30 | 2.30M shares 10-Q · filed 2019-08-08 | 34.53M shares 10-Q · filed 2018-08-10 | ||||||
| 2018-03-31 | 2.33M shares 10-Q · filed 2019-05-09 | 34.98M shares 10-Q · filed 2018-05-10 | ||||||
| 2017-12-31 | 768.56K shares 10-K · filed 2019-03-19 | 11.53M shares 10-K · filed 2018-04-02 | ||||||
| 2017-09-30 | 16.53M shares 10-Q · filed 2018-11-13 | 3.21M shares 10-Q · filed 2018-11-13 | ||||||
| 2017-06-30 | 14.21M shares 10-Q · filed 2018-08-10 | |||||||
| 2017-03-31 | 29.47M shares 10-Q · filed 2018-05-10 | |||||||
| 2016-12-31 | 3.44M shares 10-K · filed 2018-04-02 | |||||||
| 2016-09-30 | 3.23M shares 10-Q · filed 2017-11-13 | 3.23M shares 10-Q · filed 2017-11-13 | ||||||
| 2016-06-30 | 2.70M shares 10-Q · filed 2017-08-14 | 24.73M shares 10-Q · filed 2016-08-15 | ||||||
| 2016-03-31 | 2.72M shares 10-Q · filed 2017-05-15 | 24.99M shares 10-Q · filed 2016-05-16 | ||||||
| 2015-12-31 | 1.94M shares 10-K · filed 2017-03-31 | 7.79M shares 10-K · filed 2016-03-25 | ||||||
| 2015-09-30 | 6.98M shares 10-Q · filed 2016-11-14 | |||||||
| 2015-06-30 | 69.81M shares 10-Q · filed 2016-08-15 | |||||||
| 2015-03-31 | 68.96M shares 10-Q · filed 2016-05-16 | 8.33M shares 10-Q · filed 2015-05-11 | ||||||
| 2014-12-31 | 8.47M shares 10-K · filed 2016-03-25 | |||||||
| 2014-03-31 | 1.50M shares 10-Q · filed 2015-05-11 | 315.00K shares 10-Q · filed 2014-05-20 | ||||||
| 2013-12-31 | 907.50K shares 10-K · filed 2015-04-03 | 281.67K shares 10-K/A · filed 2014-04-23 | ||||||
| 2013-09-30 | 28.17M shares 10-Q · filed 2013-11-19 | |||||||
| 2013-06-30 | 28.17M shares 10-Q · filed 2013-08-14 | |||||||
| 2013-03-31 | 31.50M shares 10-Q/A · filed 2013-05-20 | |||||||
| 2012-03-31 | 21.25M shares 10-Q/A · filed 2013-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |